Drug-Eluting Stents Market

DelveInsight’s Drug-Eluting Stents market report provides a thorough comprehension of Drug-Eluting Stents and historical and forecasted Drug-Eluting Stents market trends in the 7MM (the United States, EU5 (Germany, France, Spain, Italy, and the United Kingdom), and Japan). 

Some of the Key Highlights from the Drug-Eluting Stents Market Report

• The major companies active in the Drug-Eluting Stents market include Abbott, Braun Melsungen AG, Biosensors International Group, Ltd, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Terumo Corporation, Medtronic, MicroPort Scientific Corporation, Lepu Medical, Cook, Medinol Ltd, Cardinal Health, among others.

• The FDA-approved Drug-Eluting Stents available in the market include EluNIR, SYNERGY™ XD, XIENCE SIERRA, Coroflex® ISAR NEO, BA9™, Orsiro, and several others.

• SYNERGY XD by Boston Scientific Corporation is a bioabsorbable everolimus-eluting stent of the next generation.

• EluNIR by Medinol is the first drug-eluting stent made of elastomeric material. It’s made from a thin cobalt-chrome alloy. Ridaforolimus Eluting Coronary Stent System is a stent known for its unique flexibility, conformability, and scaffolding.

• The Drug-Eluting Stents market is segmented by Type, Scaffold, and End Users.

Request for the Webex demo of the report @ Drug-Eluting Stents Market Outlook

Drug-Eluting Stents: Overview

Stents are small, expandable tubes that are inserted following percutaneous coronary intervention (PCI) to keep arteries open and improve blood flow. Stents are divided into two types: bare-metal stents and drug-eluting stents. Drug-Eluting Stents are coated with medications that slowly elute to prevent scar tissue buildup in the artery lining.

Drug-Eluting Stents Market

The total Drug-Eluting Stents market size is segmented by type, which includes coronary and peripheral stents. The Drug-Eluting Stents market is expected to grow due to a shift in preference for drug-eluting stents over angioplasty. The Drug-Eluting Stents market is expected to grow due to a change in preference for drug-eluting stents over angioplasty. The growing burden of the elderly population, combined with a sedentary lifestyle, is expected to increase the prevalence of atherosclerosis, thereby fueling the Drug-Eluting Stents market. Furthermore, the demand for minimally invasive procedures is a driving factor.

Find out which player or device is going to get the maximum share @ Drug-Eluting Stents Market Size

Drug-Eluting Stents Key Companies 

• Abbott

• Braun Melsungen AG

• Biosensors International Group, Ltd

• BIOTRONIK SE & Co. KG

• Boston Scientific Corporation

• Terumo Corporation

• Medtronic

• MicroPort Scientific Corporation

• Lepu Medical

• Cook

• Medinol Ltd

• Cardinal Health

Drug-Eluting Stents Market Drivers

• Increase in prevalence of artery blockage due to sedentary lifestyle and growing geriatric population

• Technological advancement in the field of drug-eluting stenting

Drug-Eluting Stents Market Barriers

• The risk associated with the stents

• The dearth of skilled healthcare professionals

Drug-Eluting Stents Unmet Needs 

• Incomplete inhibition of restenosis (especially in complex lesions)

Scope for the Report

Coverage: 7MM (the US, EU5 (the UK, Germany, Italy, Spain, and France) and Japan)

Study Period: 2018-26

Drug-Eluting Stents Key Companies: Abbott, Braun Melsungen AG, Biosensors International Group, Ltd, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Terumo Corporation, Medtronic, MicroPort Scientific Corporation, Lepu Medical, Cook, Medinol Ltd, Cardinal Health, among others. 

Tools Used: PEST Analysis

KOL’s Views

Table of Contents 

Get in touch with our business executive for Healthcare Due Diligence Services

Related Reports

Coronary Stents Market

Get a comprehensive analysis of Coronary Stents pipeline devices and key companies, including Medtronic, Abbott, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, among others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/